Genprex Retains Addison Whitney for Drug Nomenclature Branding
Genprex takes next steps toward identifying drug name for future commercialization AUSTIN, Texas & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Genprex, Inc. (NASDAQ: GNPX),…
Pharmaceuticals, Biotechnology and Life Sciences
Genprex takes next steps toward identifying drug name for future commercialization AUSTIN, Texas & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Genprex, Inc. (NASDAQ: GNPX),…
STONY BROOK, N.Y.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24apdn&src=ctag" target="_blank"gt;$apdnlt;/agt; lt;a href="https://twitter.com/hashtag/anticounterfeiting?src=hash" target="_blank"gt;#anticounterfeitinglt;/agt;–Applied DNA Sciences, Inc. (NASDAQ:APDN), announced today that American & Efird (A&E),…
ANN ARBOR, Mich.–(BUSINESS WIRE)–Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage biopharmaceutical company developing novel treatments for orphan endocrine diseases, announced…
SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/ALS?src=hash" target="_blank"gt;#ALSlt;/agt;–Neuropore Therapies, Inc. announced today that it has initiated a Phase 1 clinical trial in healthy…
Sixth pharma partner to internalize the Adimab platform LEBANON, N.H.–(BUSINESS WIRE)–Adimab, LLC, the global leader in the discovery and optimization…
LEBANON, N.H.–(BUSINESS WIRE)–Adimab, LLC, the leading provider of antibody discovery and optimization technology, today announced the expansion of an earlier…
LEBANON, N.H.–(BUSINESS WIRE)–Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, announced…
VIENNA, Va.–(BUSINESS WIRE)–The following letter was sent by CEL-SCI Corporation (NYSE American: CVM) to its shareholders: Dear CEL-SCI Shareholders: The…
– Conference Call and Webcast Today, May 8, 2019, at 8:00 a.m. ET – NEW YORK–(BUSINESS WIRE)–IVERIC bio (Nasdaq: ISEE)…
— First-Quarter 2019 Net Sales of $280.4 Million Increased 25 Percent; First-Quarter 2019 GAAP Net Loss of $32.9 Million; Adjusted…